AA
VTAE

ALPS Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

ALPS Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-36,767
Closed -$769K – 750
2016
Q3 		$769K Sell
36,767
-3,748
-9% -$43.2K 0.01% 236
2016
Q2 		$437K Buy
40,515
+15,920
+65% +$136K ﹤0.01% 359
2016
Q1 		$163K Sell
24,595
-4,215
-15% -$38.3K ﹤0.01% 609
2015
Q4 		$521K Sell
28,810
-5,394
-16% -$74.2K 0.01% 393
2015
Q3 		$3.77K Buy
34,204
+12,526
+58% +$133K ﹤0.01% 633
2015
Q2 		$312K Buy
+21,678
New +$294K ﹤0.01% 653

ALPS Advisors's VTAE Position: Q4 2016 in Review

ALPS Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 36,767 shares — an estimated $769K sold.

ALPS Advisors first reported a position in VTAE in Q2 2015 and held it in 6 quarters. The position peaked at $769K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • ALPS Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • ALPS Advisors sold 36,767 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $769K.
  • ALPS Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 6 quarters.
  • ALPS Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $769K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.